Using OIR in vivo model and rat aortic ring ex vivo model, we showed that AS1411 induced an inhibition in neoangiogenesis similarly as ranibizumab did, which is a VEGF-inhibitor clinically approved for human retinopathies. Here, VEGFA is linked to retinal disorder.